Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-08-14 1:47 pm Purchase | 2025-06-30 | 13G | Xilio Therapeutics, Inc. XLO | Frazier Life Sciences Public Fund, L.P. | 8,141,017 9.900% | 2,393,824![]() (+41.65%) | Filing |
2025-06-12 4:55 pm Purchase | 2025-06-05 | 13G | Xilio Therapeutics, Inc. XLO | Frazier Life Sciences Public Fund, L.P. | 5,747,193 9.900% | 5,747,193![]() (New Position) | Filing |